SEC Form 4 · accession 0001209191-18-061249
Odonate Therapeutics, Inc. · ODT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Laura L. Douglass
Director
Period of report
Dec 3, 2018
Accepted (ET)
Dec 6, 2018 · 4:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001717452
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.79 | Dec 3, 2018 | A | 35,000 | A | — | Dec 3, 2028 | Common Stock | 35,000 | 35,000 | D |
Explanation of responses
- F1The stock options vest with respect to 25% of the underlying shares on 12/03/2019, with the remaining shares vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer through each vesting date.